Alpha-Blockade in the Treatment of Symptomatic Benign Prostatic Hyperplasia
- 1 September 1995
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 154 (3) , 923-934
- https://doi.org/10.1016/s0022-5347(01)66936-2
Abstract
No abstract availableThis publication has 91 references indexed in Scilit:
- Alpha1-adrenoceptors in human prostate: Characterization and binding characteristics of alpha1-antagonistsLife Sciences, 1994
- Long‐term treatment of benign prostatic hyperplasia with alfuzosin: a 24–30 month surveyBritish Journal of Urology, 1994
- Benign Prostatic HyperplasiaDrugs, 1994
- Long‐term Treatment of Benign Prostatic Hyperplasia with Alfuzosin: a 12–18 Month AssessmentPublished by Wiley ,1993
- Urinary Flow Rates in Patients with Benign Prostatic Hypertrophy following Treatment with AlfuzosinBritish Journal of Urology, 1992
- The response to alpha blockade in benign prostatic hyperplasia is related to the percent area density of prostate smooth muscleThe Prostate, 1992
- Terazosin: Pharmacokinetics and the effect of age and dose on the incidence of adverse eventsAmerican Heart Journal, 1991
- The Density of Cholinergic and Alpha and Beta Adrenergic Receptors in the Normal and Hyper‐reflexic Human DetrusorBritish Journal of Urology, 1989
- Prazosin in the Treatment of Prostatic Obstruction A Placebo‐controlled StudyBritish Journal of Urology, 1987
- TerazosinDrugs, 1987